专利检索 ap:("CHILDREN'S HOSPITAL MEDICAL CENTER" OR "THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC") AND inv:"Jian-Kang JIANG" 第 1 页

1.

发明申请
Substituted Imidazo[l,2-a]-pyridines as IRAK 1/4 and FLT3 Inhibitors 有权

公开(公告)号：US20220213094A1

公开(公告)日：2022-07-07

申请号：US17568023

申请日：2022-01-04

申请人： CHILDREN'S HOSPITAL MEDICAL CENTER , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC

发明人： Daniel T. STARCZYNOWSKI , Craig J. THOMAS , Garrett RHYASEN , Katelyn MELGAR , Morgan MacKenzie WALKER , Jian-Kang JIANG

IPC分类号： C07D471/04 , A61P35/02

摘要： Some embodiments of the invention include inventive compounds (e.g., compounds of Formula (I)). Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inventive compound. Still other embodiments of the invention include compositions (e.g., pharmaceutical compositions) for treating, for example, certain diseases using the inventive compounds. Some embodiments include methods of using the inventive compound (e.g., in compositions or in pharmaceutical compositions) for administering and treating (e.g., diseases such as cancer or blood disorders). Further embodiments include methods for making the inventive compounds. Additional embodiments of the invention are also discussed herein.